Atai Beckley N.V
46.5M
$924.26M
-1.40
$-2.91
No price alerts set. Add an alert to get notified!
-1.40
4.18
$-2.91
-297.32%
-16,142.02%
-2,789.46%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
AMLX
Amylyx Pharmaceuticals, Inc.
|
$17.57 | -4.30% | -11.48 | $1.46B | 0.02 |
|
DNTH
Dianthus Therapeutics, Inc.
|
$91.92 | -1.44% | 0.00 | $3.53B | 0.00 |
|
ELVN
Enliven Therapeutics, Inc.
|
$46.41 | -3.53% | -25.36 | $2.78B | 0.00 |
|
IMTX
Immatics N.V.
|
$11.25 | 0.72% | -6.39 | $1.51B | 0.03 |
|
INBX
Inhibrx Biosciences, Inc.
|
$82.39 | -6.62% | -9.11 | $1.20B | 13.39 |
|
NKTR
Nektar Therapeutics
|
$100.35 | 18.25% | -12.41 | $2.04B | 1.66 |
|
ORIC
ORIC Pharmaceuticals, Inc.
|
$10.89 | 1.30% | -7.38 | $1.09B | 0.03 |
|
RLAY
Relay Therapeutics, Inc.
|
$16.40 | -2.15% | -10.18 | $2.93B | 0.06 |
|
SANA
Sana Biotechnology, Inc.
|
$3.82 | 8.52% | -3.96 | $1.02B | 0.49 |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$23.78 | -1.86% | -7.22 | $2.10B | 5.36 |
* Peer stocks are selected based on market capitalization and sector
$6.75
$1.29
$0.00
0.00%
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
